Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
STIM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FGFR4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA0922 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTCD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AHCYL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENSA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUFIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA1024 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APOM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CADM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLASP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on